Jan 25–28, 2027 | Keystone Resort, Keystone, CO, United States
              
              Scientific Organizers:
              
                 
                  C. Frank Bennett, Beverly L. Davidson, and Daniel G. Anderson
                
                      
            
 
        -
Scientific Organizers: C. Frank Bennett, Beverly L. Davidson, and Daniel G. Anderson
C. Frank Bennett, PhD
Ionis Pharmaceuticals, Inc.
Beverly L. Davidson, PhD
Children’s Hospital of Philadelphia and University of Pennsylvania
Daniel G. Anderson, PhD
Massachusetts Institute of Technology
***Meeting program subject to change.
Available Formats: = In Person = On DemandMerchandise Options
Registration Options
Monday, January 25, 2027
Tuesday, January 26, 2027
Single-AAV base Editing Therapies for Duchenne Muscular Dystrophy
AAV Capsid Engineering for Broad CNS Distribution
Development of Medicines to Treat Prion Diseases: A Personal Journey
AAV-Delivered Epigenome Editors
LNP Delivery of Nucleic Acid Medicines
LNP Delivery with the CNS
Optimizing LNPs Delivery Vehicles
Wednesday, January 27, 2027
Development and Application of Virus-Like Particles for Genome Editing in vivo
mRNA/LNP based Gene Editing
Personalized Therapeutic Genome Editing for Hepatic Inborn Errors of Metabolism
Novel Delivery Strategies for Genetic Medicines
Machine Learning Design of Ligands for Targeted Delivery of Nucleic Acid Medicines
Novel Ligands for Cell Selective Gene Silencing
Targeted Delivery of Oligonucleotide Drugs
Thursday, January 28, 2027
Tissue Selective Delivery of Circular RNAs
Genome Editing in vivo via Non-Viral Delivery Platforms
AAV and Bocavirus Vector Engineering
AAV Delivery to Cancer Cells
VLP Deliver of cas Enzymes
Target LNPs for In Vivo T Cell Engineering
AI-Driven Development of Nonviral Delivery Tools for Nucleic Acid Medicines
Friday, January 29, 2027
Subscribe for Updates